AMGN Amgen Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

AMGN [NASD]

Amgen Inc.

Healthcare | Drug Manufacturers - General | USA

statements

Index	DJIA S&P500	P/E	17.68	EPS (ttm)	12.24	Insider Own	0.20%	Shs Outstand	588.00M	Perf Week	-5.50%
Market Cap	127.19B	Forward P/E	12.88	EPS next Y	16.80	Insider Trans	-0.40%	Shs Float	584.66M	Perf Month	-12.86%
Income	7.30B	PEG	2.58	EPS next Q	3.80	Inst Own	78.10%	Short Float	1.05%	Perf Quarter	-12.09%
Sales	24.30B	P/S	5.23	EPS this Y	2.00%	Inst Trans	-0.08%	Short Ratio	2.28	Perf Half Y	-9.55%
Book/sh	18.13	P/B	11.93	EPS next Y	6.56%	ROA	11.90%	Target Price	260.79	Perf Year	3.54%
Cash/sh	19.43	P/C	11.14	EPS next 5Y	6.84%	ROE	71.70%	52W Range	177.05 - 264.97	Perf YTD	-10.24%
Dividend	6.40	P/FCF	19.29	EPS past 5Y	14.00%	ROI	21.20%	52W High	-18.51%	Beta	0.74
Dividend %	2.96%	Quick Ratio	1.80	Sales past 5Y	3.10%	Gross Margin	78.20%	52W Low	21.95%	ATR	5.94
Employees	23400	Current Ratio	2.20	Sales Q/Q	5.70%	Oper. Margin	37.90%	RSI (14)	27.17	Volatility	1.97% 2.43%
Optionable	Yes	Debt/Eq	3.21	EPS Q/Q	-14.70%	Profit Margin	30.00%	Rel Volume	1.40	Prev Close	216.38
Shortable	Yes	LT Debt/Eq	3.20	Earnings	Oct 28 AMC	Payout	49.50%	Avg Volume	2.68M	Price	215.92
Recom	2.40	SMA20	-8.93%	SMA50	-11.02%	SMA200	-6.86%	Volume	670,884	Change	-0.21%

Oct-28-20

Initiated

UBS

Neutral

$232

Oct-26-20

Upgrade

Raymond James

Mkt Perform → Outperform

$255

Oct-12-20

Upgrade

Truist

Hold → Buy

Oct-09-20

Downgrade

Truist

Buy → Hold

$251

Oct-09-20

Downgrade

Bernstein

Outperform → Mkt Perform

Oct-08-20

Downgrade

Raymond James

Outperform → Mkt Perform

Apr-15-20

Resumed

Guggenheim

Neutral

Mar-31-20

Initiated

Wolfe Research

Peer Perform

Mar-30-20

Upgrade

Raymond James

Mkt Perform → Outperform

$255

Mar-05-20

Upgrade

BofA/Merrill

Neutral → Buy

$245 → $250

Feb-27-20

Initiated

Barclays

Equal Weight

$235

Jan-31-20

Downgrade

Robert W. Baird

Neutral → Underperform

$173 → $185

Jan-21-20

Upgrade

Evercore ISI

In-line → Outperform

Dec-24-19

Initiated

Raymond James

Mkt Perform

Dec-17-19

Resumed

Morgan Stanley

Overweight

$280

Nov-12-19

Initiated

SunTrust

Buy

$256

Nov-05-19

Upgrade

Cantor Fitzgerald

Neutral → Overweight

$230 → $255

Oct-17-19

Resumed

BofA/Merrill

Neutral

$215

Aug-19-19

Downgrade

Mizuho

Buy → Neutral

$208 → $212

May-23-19

Upgrade

Citigroup

Neutral → Buy

Oct-29-20 06:05AM	Thank Otezla for Amgen's Q3 Revenue and Earnings Beats Motley Fool
05:15AM	Amgens 3Q Top Line Gains 12% Fueled By Strong Drug Sales SmarterAnalyst
Oct-28-20 10:31PM	Amgen Inc (AMGN) Q3 2020 Earnings Call Transcript Motley Fool
06:51PM	Amgens Earnings and Sales Climb, Driven by Its Biosimilars Barrons.com
05:30PM	Amgen Earnings, Sales Top Wall Street Views; Hikes Earnings Guidance Investor's Business Daily
05:15PM	Amgen (AMGN) Q3 Earnings and Revenues Beat Estimates Zacks
04:47PM	Amgen Reports Stronger-Than-Expected Q3 Earnings; Revenue Gains 12% TheStreet.com
04:30PM	Recap: Amgen Q3 Earnings Benzinga
04:09PM	Osteoporosis drug helps Amgen third-quarter profit beat estimates Reuters
04:02PM	Osteoporosis drug helps Amgen third-quarter profit beat estimates Reuters
04:01PM	Amgen Reports Third Quarter 2020 Financial Results PR Newswire
03:00PM	Amgen, Inc. to Host Earnings Call ACCESSWIRE
10:24AM	Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More Zacks
06:42AM	How Does Amgen's (NASDAQ:AMGN) CEO Salary Compare to Peers? Simply Wall St.
Oct-27-20 06:57PM	Amgen Announces Webcast Of 2020 Third Quarter Financial Results PR Newswire
04:00PM	Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program PR Newswire
11:59AM	Drug/Biotech Stock Q3 Earnings on Oct 28: GSK, AMGN & More Zacks
11:29AM	The Zacks Analyst Blog Highlights: Pfizer, Merck & Co., Bristol-Myers Squibb and Amgen Zacks
10:08AM	3 Biotech Stocks I'd Buy Right Now Motley Fool
10:05AM	Amgen's Earnings Outlook Benzinga
07:53AM	Better Buy: Amgen vs. Mirati Therapeutics Motley Fool
Oct-26-20 04:23PM	Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug Investor's Business Daily
12:05PM	Were Hedge Funds Right About Souring On Amgen, Inc. (AMGN)? Insider Monkey
11:32AM	Why Mirati Therapeutics Stock Is Taking Off Today Motley Fool
Oct-24-20 06:00AM	Cancer Meeting Could Ignite These Biotech Stocks Barrons.com
Oct-23-20 01:29PM	3 Newly Recruited Dow Jones Stocks to Trade InvestorPlace
12:52PM	Hedge Fund Darling Miratis $5 Billion Stock Rally Set for Test Bloomberg
10:05AM	Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus Zacks
08:25AM	Amgen (AMGN) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-22-20 10:15AM	Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus Zacks
Oct-21-20 04:00PM	Amgen Announces 2020 Fourth Quarter Dividend PR Newswire
12:33PM	Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Oct-20-20 09:02AM	Is Amgen Stock A Buy With No Recent Updates On Its Dual Approach To Targeting Coronavirus? Investor's Business Daily
Oct-18-20 09:30AM	Better Buy: Amgen vs. Bristol Myers Squibb Motley Fool
Oct-16-20 01:31PM	Top Research Reports for Novartis, Zoom Video & FIS Zacks
Oct-14-20 10:10AM	Biotech Stock Roundup: REGN, GILD's Coronavirus News & Other Pipeline Updates Zacks
08:35AM	Got $500? 3 Big Pharma Stocks You Can Buy Now That Pay Dividends Motley Fool
06:45AM	2 Cheap Dividend Stocks You Can Buy Right Now Motley Fool
Oct-09-20 12:46PM	Amgen Down on Unsatisfactory Heart Failure Drug Study Results Zacks
Oct-08-20 04:13PM	Amgen and Cytokinetics Stocks Slide After Heart Drug Trial Results Barrons.com -6.82%
01:08PM	Stock Market Pares Early Gains On Unexpected Spike In Jobless Claims Investor's Business Daily
08:58AM	Signs That Your Trading Will Ruin Your Retirement - October 08, 2020 Zacks
08:30AM	Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure PR Newswire
08:30AM	Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure GlobeNewswire
Oct-07-20 01:54PM	Dow Jones Gains As Bull Charge Wipes Out Losses; These Stocks Break Out Investor's Business Daily
Oct-06-20 01:19PM	The Zacks Analyst Blog Highlights: Amgen, Exxon Mobil, S&P Global, HSBC and LULU Zacks
09:48AM	Amgen Says Study Results on Its Novel Cancer Drug Were Positive Barrons.com
Oct-05-20 04:31PM	President Trump's Hospital Departure Fuels Dow Jones Rally; These Stocks Break Out Investor's Business Daily
04:30PM	Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer PR Newswire
04:26PM	Bristol Myers Squibb To Add To Heart Treatment Portfolio With $13.1 Billion Acquisition Investor's Business Daily
03:48PM	Semiconductors, Biotechs Send Nasdaq Soaring Motley Fool
02:05PM	Dow Surges 450 Points As Stock Market Rallies After Trump Tweet Investor's Business Daily
01:36PM	Top Stock Reports for Amgen, Exxon Mobil & S&P Global Zacks
12:10PM	Why the Earnings Surprise Streak Could Continue for Amgen (AMGN) Zacks
Oct-03-20 06:45AM	Market Crash 2.0: 3 Stocks to Save Your Portfolio Motley Fool
04:05AM	Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® (erenumab-aooe) In Adult Patients With Episodic Migraine PR Newswire
Oct-02-20 01:42PM	Dow Jones Cuts Loss On Stimulus Deal Hopes; Trump Quarantines, Biden Tests Negative Investor's Business Daily
09:52AM	Congressional Committee Accuses Amgen and Peers of Hiking Drug Prices to Meet "Aggressive" Revenue Targets Motley Fool
Sep-30-20 04:51PM	Dow Jones Rises 330 Points, Leads Market Higher; Several Leading Stocks Break Out Investor's Business Daily
03:23PM	American Express, Walmart share gains contribute to Dow's 169-point climb MarketWatch
12:21PM	American Express, Amgen Inc. share gains contribute to Dow's 488-point rally MarketWatch
Sep-29-20 05:42PM	Regeneron Posts Positive Initial Data On Its Covid-19 Treatment Investor's Business Daily
06:04AM	Better Buy: Gilead Sciences vs. Amgen Motley Fool
Sep-28-20 06:25AM	What Amgen Inc.'s (NASDAQ:AMGN) P/E Is Not Telling You Simply Wall St.
Sep-24-20 09:46AM	Dow's 129-point drop led by losses for Boeing, Walt Disney shares MarketWatch
Sep-22-20 03:45PM	Dow's 162-point jump led by gains for Nike, Microsoft shares MarketWatch
02:41PM	Dow's nearly 100-point climb led by gains for shares of Nike, Microsoft MarketWatch
Sep-21-20 10:42AM	Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain. Barrons.com
08:05AM	Trump's Pep Talk Raises Vaccine Hopes: 4 Stocks to Watch Zacks
06:31AM	Dow Jones Changes Could Impact Investor Portfolios Motley Fool
Sep-20-20 08:39AM	Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine PR Newswire
08:25AM	Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation -study Reuters
Sep-19-20 07:00AM	Where Will Amgen Be in 1 Year? Motley Fool
Sep-18-20 04:16PM	High Hopes for Amgen and Gilead at Europes Biggest Cancer Research Conference Barrons.com
12:41PM	Lilly, Amgen Ink Manufacturing Deal for Coronavirus Antibodies Zacks
Sep-17-20 04:31PM	Eli Lilly, Amgen Teaming Up On Covid-19 Treatments Investor's Business Daily
11:00AM	Coronavirus update: Vaccine makers ramp up manufacturing as Trump stirs debate; NYC to delay school reopen Yahoo Finance
09:37AM	Eli Lilly Reaches COVID-19 Antibody Therapy Manufacturing Deal With Amgen TheStreet.com
06:41AM	Eli Lilly and Amgen to collaborate on COVID-19 antibody therapies MarketWatch
06:30AM	Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies PR Newswire
Sep-16-20 04:15PM	Amgen To Webcast Investor Calls At ESMO 2020 PR Newswire
04:00PM	Amgen To Showcase Data From Oncology Pipeline During ESMO Virtual Congress 2020 PR Newswire
06:06AM	The Dow Jones' 5 Most Important Stocks Motley Fool
Sep-15-20 11:53AM	Dow's 100-point jump highlighted by gains for shares of Dow Inc., Intel MarketWatch
09:00AM	Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket PR Newswire
Sep-14-20 04:00PM	Amgen To Present At The 2020 Bank of America Virtual Global Healthcare Conference PR Newswire
08:00AM	2 No-Brainer Stocks to Buy in Biotech Motley Fool
06:25AM	2 No-Brainer Stocks to Buy In Pharma Motley Fool
Sep-11-20 04:00PM	Amgen To Present At The 18th Annual Morgan Stanley Global Healthcare Conference PR Newswire
09:45AM	Nike, Amgen Inc. share gains lead Dow's 118-point jump MarketWatch
06:40AM	2 Top Dividend Stocks to Buy in a Stock Market Crash Motley Fool
Sep-10-20 03:18PM	Dow drops nearly 425 points on losses for Apple Inc., Microsoft stocks MarketWatch
02:17PM	Dow's 211-point fall led by losses for Apple Inc., Caterpillar stocks MarketWatch
Sep-08-20 01:58PM	The Zacks Analyst Blog Highlights: Moderna, Sanofi, GSK, GILD and AMGN Zacks
Sep-04-20 04:00PM	Amgen To Present At The 15th Annual Citi BioPharma Conference PR Newswire
06:59AM	Vaccine Hopes Rise Again: 4 Stocks to Watch Zacks
Sep-02-20 02:45PM	How Dow changes are impacting ETF investing Yahoo Finance Video
12:12PM	Dow Jones Up 200 Points But Nasdaq Falters As Apple Stock, Tesla Weigh Investor's Business Daily
10:56AM	Is Amgen (AMGN) a Good Choice for Dow Membership? Investopedia
06:00AM	I have a problem with Tesla: Billionaire Investor Yahoo Finance Video

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SUGAR RONALD D	Director	Aug 19	Option Exercise	54.69	1,000	54,690	16,589	Aug 19 06:00 PM
SUGAR RONALD D	Director	Aug 19	Sale	241.02	1,000	241,020	15,589	Aug 19 06:00 PM
Williams R Sanders	Director	Aug 07	Sale	242.95	250	60,738	5,159	Aug 10 05:42 PM
SUGAR RONALD D	Director	Jul 22	Option Exercise	54.69	1,000	54,690	16,589	Jul 22 06:11 PM
SUGAR RONALD D	Director	Jul 22	Sale	259.79	1,000	259,790	15,589	Jul 22 06:11 PM
SUGAR RONALD D	Director	Jun 17	Option Exercise	54.69	1,000	54,690	16,576	Jun 17 06:11 PM
SUGAR RONALD D	Director	Jun 17	Sale	228.54	1,000	228,540	15,576	Jun 17 06:11 PM
SUGAR RONALD D	Director	May 20	Option Exercise	54.69	1,000	54,690	16,482	May 20 09:24 PM
SUGAR RONALD D	Director	May 20	Sale	229.27	1,000	229,270	15,482	May 20 09:24 PM
Williams R Sanders	Director	May 06	Sale	237.31	425	100,857	5,409	May 07 08:49 PM
SUGAR RONALD D	Director	Apr 22	Option Exercise	54.69	1,000	54,690	15,636	Apr 22 07:07 PM
SUGAR RONALD D	Director	Apr 22	Sale	233.35	1,000	233,350	14,636	Apr 22 07:07 PM
Bradway Robert A	Chairman, CEO and President	Apr 13	Option Exercise	58.43	127,000	7,420,610	595,516	Apr 13 07:54 PM
Williams R Sanders	Director	Feb 06	Sale	233.72	425	99,331	4,988	Feb 10 09:33 PM
Piacquad David	SVP, Business Development	Feb 06	Sale	229.93	9,264	2,130,079	39,700	Feb 07 08:25 PM
Meline David W	EVP & CFO	Nov 25	Sale	234.36	8,737	2,047,603	49,378	Nov 25 06:27 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 22	Sale	230.54	9,000	2,074,837	42,853	Nov 25 06:25 PM
Piacquad David	SVP, Business Development	Nov 20	Option Exercise	156.35	5,749	898,856	53,361	Nov 20 08:09 PM
SUGAR RONALD D	Director	Nov 06	Option Exercise	54.71	2,000	109,420	16,436	Nov 07 06:20 PM
Williams R Sanders	Director	Nov 06	Sale	215.45	425	91,566	5,413	Nov 07 06:22 PM
SUGAR RONALD D	Director	Nov 06	Sale	215.45	2,000	430,900	14,436	Nov 07 06:20 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience